{"database": "openregs", "table": "documents", "rows": [["FDA-2002-N-0194-0002", "FDA", "FDA-2002-N-0194", "Agency Information Collection Activities; Submission for OMB Review; Comment Request; New Drug\nand Biological Drug Products; Evidence Needed to Demonstrate Effectiveness of New Drugs When Human Efficacy Studies Are Not Ethical or Feasible", "Notice", "General Notice", "2003-03-16T05:00:00Z", 2003, 3, "2003-03-07T05:00:00Z", "2003-04-08T03:59:59Z", "2025-05-13T09:45:34Z", "03-5357", 0, 0, "0900006480495892"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2002-N-0194-0002"], "units": {}, "query_ms": 21.507024997845292, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}